Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

Potential Sale of SK Specialty and Deleveraging of the SK Group - Impact on SK Inc and NAV Analysis

Updated NAV on SK Inc Post 660 Billion Pre-IPO Investment in SK Pharmteco

Impact on SK Inc Post Record Divorce Ruling for SK Group Chairman Chey Tae-Won

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Douglas Research Advisory

Equity Bottom-Up

<ul>
<li>On 28 October, SK Inc (034730 KS) announced its corporate value up program.</li>
<li>Minimum annual DPS was set at 5,000 won. The combination of dividends and share buyback/cancellations would mean that the total shareholder returns could range about 4% to 5% per year. </li>
<li>The company announced its goal of improving its ROE to around 10% in the long-term. From 2021 to 2023, the company's ROE averaged 3.9%.</li>
</ul>


On 28 October, SK Inc (034730 KS) announced its corporate value up program.
Minimum annual DPS was set at 5,000 won. The combination of dividends and share buyback/cancellations would mean that the total shareholder returns could range about 4% to 5% per year. 
The company announced its goal of improving its ROE to around 10% in the long-term. From 2021 to 2023, the company's ROE averaged 3.9%.


SK Inc: Solid Corporate Value Up Plan Muddled by Chairman Chey's Ongoing Divorce Proceeding